Abstract

Article Series: Dual Energy CT – Scientific Evidence and Clinical Application (4/7) – Abdominal Imaging

posted by Thorsten R. C. Johnson, M.D. | Dec 10, 2010

This article is part of the seven-article series on “Dual Energy CT – Scientific Evidence and Clinical Application”. T. Johnson, MD, talks about Dual Energy applications in abdominal imaging comprising imaging of the liver, the biliary system, the kidneys, the adrenal glands, pancreas, colon, aorta, and plaque imaging.

Abdominal Imaging

Liver Imaging

In abdominal imaging, iodine enhancement is the main diagnostic feature in the characterization of organ lesions, especially in the liver. Although a specific identification and quantification of the enhancement would be desirable, standard CT examination protocols mostly rely on one single venous phase to avoid the radiation exposure of multi-phase exams. With Dual Energy CT, it is feasible to identify iodine by its photo effect and to quantify the iodine-related density [72]. With this information, it is possible to subtract the iodine-related density from the CT image to generate a “virtual” non-contrast image from the same dataset. As the iodine related density is derived from the difference of two image datasets, the noise is doubled in this virtual non-contrast image. Although the image quality is therefore not exactly equivalent to a true pre-contrast acquisition, several studies confirmed that this virtual non-contrast image is sufficient to assess and quantify the enhancement of focal liver lesions [73-75].
The detection and quantification of iodine can also be used to assess vitality and monitor therapy response. For example, a study showed good results in evaluating liver lesions after radiofrequency ablation [76]. Limitations with the first generation DSCT were the limited field of view and the high noise in the 80 kVp image deteriorating image quality in large patients [8]. These issues are largely resolved with the second generation system and its spectral filter and larger field of view, as previously mentioned.

Apart from providing virtual non-contrast images and quantifying the iodine content of lesions, Dual Energy CT can also increase the conspicuity of lesions. Two studies showed that the contrast of hypervascular lesions is increased in low energy images and that an optimal compromise between contrast and image noise can be found by altering the weighting factor for average image generation [77-78]. Sigmoidal blending algorithms may be the best option for this purpose, combining the high contrast of low energy acquisitions with the low noise of high energy acquisitions [16].

Biliary system

Regarding gall stones, a clinically relevant difference is the composition which mostly contains calcium, cholesterol or pigment. As cholesterol stones can be dissolved medically, this would imply a non-invasive treatment option, while other types of stones would have to be removed mechanically if symptomatic. In vitro experiments have confirmed that Dual Energy CT can reliably differentiate cholesterol from other stones [79-80]. However, there are previous single energy CT studies that showed that this differentiation is also feasible based normal single energy CT density [81-82]. Therefore, the specific advantage of Dual Energy CT in this application is not evident.

Other researchers describe the use of iodinated biliary contrast material for cholangiography. Here, optimized blending or specific depiction of iodine can improve the visualization of the biliary system [83]. Still, the poor tolerance of biliary contrast agents [84] and the availability of MRCP as alternative reserves this technique to special indications such as living donor examinations in the preparation of liver transplantation.

Kidney Imaging

Figure 4 Multiplanar reformat with color coded superimposition of iodine signal confirming the absence of enhancement in cysts of variable density.

Figure 4 Multiplanar reformat with color coded superimposition of iodine signal confirming the absence of enhancement in cysts of variable density.

In kidney imaging, the assessment of contrast enhancement in small lesions is the most important diagnostic feature in the detection of cancer. If there are multiple cysts, it can be quite difficult or cumbersome to evaluate each lesion individually. However, especially patients with autosomal dominant polycystic kidney disease bear an increased risk of developing cancer. Therefore, most kidney CT protocols comprise an unenhanced, a contrast-enhanced, and a late excretory phase. Thus, it is attractive to use Dual Energy CT to specifically assess the iodine content of kidney lesions and to reduce radiation dose and postprocessing effort at the same time. Similar to the algorithms quantifying enhancement in liver lesions, iodine can be color-coded and quantified in the kidneys to differentiate hyperattenuating structures, e.g. hemorrhagic cysts, from enhancing tumors.
In an experimental study, the feasibility of differentiation of lesions containing contrast, protein, or blood was verified [85-86]. Clinical studies then confirmed the ability to distinguish hyperattenuating cysts from enhancing renal masses [87-88]. Further studies showed the advantages of the second generation DSCT with its tin filter and the large field of view. The former is necessary to obtain sufficient transmission and contrast to noise ratios at thin collimation in the abdomen; the latter is required in some patients to cover both kidneys entirely [89]. Recently, a study with histopathological correlation confirmed the ability of Dual Energy CT to predict the dignity of renal lesions [90].

Kidney Stone Differentiation

Figure 5 Color coding of kidney stones shows that the calculus in the right ureter consists of uric acid.

Figure 5 Color coding of kidney stones shows that the calculus in the right ureter consists of uric acid.

As iodine provides a very strong photoelectric effect, most clinical applications of Dual Energy CT are based on iodinated contrast material. However, the differentiation of kidney stones is a clinical application that is based on the spectral properties of the renal calculi themselves [91]. As Dual Energy CT requires a minimal dose that is higher than a low-dose single energy scan, quite a few institutions use a single energy low dose scan to detect any calculi and a second very short Dual Energy acquisition to cover just the stone [92]. This requires a physician to immediately screen the dataset for calculi while the patient is in the scanner, but works with least dose. Other institutions adopted an intermediate-dose protocol which uses less than a standard abdominal CT scan but more than a true single energy low dose scan [93].

The detailed knowledge of kidney stone composition can help to recognize the underlying disease and may in some instances guide therapy. Also, calculi consisting of uric acid can be dissolved by medication with Allopurinol and urine alkalization. Therefore, the postprocessing algorithm is tailored to differentiate uric acid from other types of stones. Another component of interest is struvite, because it indicates a bacterial infection which may require treatment. However, there is a spectral overlap between calcium and struvite so that this differentiation is not always feasible [94], while the differentiation of uric acid is reliable both in vitro [95-97] and in vivo [98-99]. The tin filter of the second generation DSCT improves the results in tiny calculi or large patients [100].

Apart from differentiating renal stones, Dual Energy CT is also used to identify calculi in contrast-enhanced urinary systems [101-102]. The detection of small stones below 3 mm diameter is limited due to volume averaging [103]. However, acute renal congestion represents a contraindication for the administration of iodinated contrast material as rupture of renal calices can be the consequence. Therefore, an unenhanced scan is acquired first at most institutions, and calculi can be differentiated or excluded before contrast material is administered.

Adrenal glands

Dual energy CT can also be used to characterize adrenal nodules [88]. A clinical study showed 50% sensitivity and 100% specificity in the differentiation of adrenal adenomas from metastases based on the differences in density in an unenhanced sequential Dual Energy acquisition [104]. Thus, MRI with opposed phase imaging and CT protocols including an early and delayed phase after contrast enhancement remain the reference standard in the differentiation of adrenal lesions. An algorithm relying on the identification of fat content in Dual Energy CT may be a further option but has not yet been investigated.

Pancreas

Figure 6 Color coded iodine image of the pancreas confirms absence of enhancement in a cystic lesion.

Figure 6 Color coded iodine image of the pancreas confirms absence of enhancement in a cystic lesion.

Similar to liver and kidney imaging, contrast enhancement plays the most important role in the detection and evaluation of pancreatic masses. By specifically color-coding iodine, Dual Energy CT can help to differentiate between normal and abnormal parenchyma [88, 105] or to confirm the absence of contrast enhancement in cystic lesions. A study in 15 patients with adenocarcinoma showed improved lesion conspicuity in the low energy images in portal venous phase.

Colon

Virtual colonoscopy is performed for screening for colorectal cancer in large trials. In this setting, the CT scan is performed at comparatively low dose and without intravenous contrast material. However, it is generally required to acquire two scans, one in supine and one in prone position, to evaluate the bowel wall in the area of remaining fluid levels. Also, virtual colonoscopy still requires complete cleansing prior to the examination, partially combined with ‘fecal tagging’, i.e. the administration of iodinated contrast material to opacify the residual fluid.
An approach with Dual Energy CT would be to eliminate iodine-containing voxels from the dataset based on the spectral information [10, 106]. Then, residual fluid is removed, so that a supine acquisition would be sufficient. If this ‘spectral cleansing’ is sufficient, it may be enough to have the patient drink iodinated contrast material with his meals but not actually cleanse the intestine. However, detailed large clinical studies with this technique will be required to confirm an equivalent diagnostic value as with ‘conventional’ virtual colonoscopy.

Aorta

Figure 7 Color coding of iodine and calcium confirms an endoleak in the thrombosed lumen of the aorta after endovascular repair.

Figure 7 Color coding of iodine and calcium confirms an endoleak in the thrombosed lumen of the aorta after endovascular repair.

Aortic imaging is generally performed with high injection rates of contrast material to achieve a strong opacification. With Dual Energy CT, the influence of the low energy acquisition on the image contrast can be increased, either by sigmoidal blending, by changing the weighting factor of average images, or by reading the low energy images. Then, the amount and injection rate of contrast can be decreased, still achieving an equivalent contrast to noise ratio [107].

Another application is the differentiation of calcium and contrast material, which can occasionally be quite difficult in the thrombosed lumen after endovascular aortic repair [108]. Several studies have shown that Dual Energy CT can help to differentiate calcifications from endoleaks [109-113]. However, most of these clinical studies applied a quantitative algorithm to color-code the degree of enhancement. Instead, there are other algorithms which aim to differentiate between calcium and iodine by their photoelectric effect and assign a different color to both (e.g. the ‘hardplaques’ algorithm), and these should be preferred for this purpose.

Plaque Imaging

Figure 8 Plaque differentiation based on Dual Energy information in a human aortic specimen shows cholesterol signal in some voxels in the center of large plaques.

Figure 8 Plaque differentiation based on Dual Energy information in a human aortic specimen shows cholesterol signal in some voxels in the center of large plaques.

Plaque imaging has been a challenging area of CT research, and it seems conceivable that Dual Energy CT may improve the differentiation of atherosclerotic plaque components. However, even aortic plaques are generally only represented by a few voxels in the dataset, and these voxels rarely consist of one single component. On the other hand, lipid and calcium as the main components have such a high and low CT density that Dual Energy techniques are not required to evaluate these plaque components. Thus, the aim would be to differentiate mid-density components such as fibrous tissue or thrombus.

So far, there is little scientific evidence on Dual Energy plaque imaging. Initial trials showed potential for an improved plaque differentiation [114-115] but note that translation into clinical application requires further developments. However, there are algorithms that aim to differentiate between contrast-opacified lumen of the vessel and hard plaques based on the spectral properties of iodine and calcium. These algorithms work well and identify the interface between calcified plaque and lumen quite precisely. This technique is especially helpful after endovascular aortic repair as it color-codes calcium and iodine differently so that calcifications in the thrombosed part of the lumen can be differentiated from endoleaks [108]. Studies aiming to apply Dual Energy techniques to differentiate soft plaque components of human atherosclerotic plaque did not yield convincing advantages so far [116-117].

References

72.    Fink C. Abdominal Imaging: Liver Imaging. In: Johnson TRC, Fink C, Schönberg SO, Reiser MF, eds. Dual Energy CT in Clinical Practice. Heidelberg: Springer, 2010:145-156.
73.    Zhang LJ, Peng J, Wu SY, Wang ZJ, Wu XS, Zhou CS, Ji XM, Lu GM. Liver virtual non-enhanced CT with dual-source, dual-energy CT: a preliminary study. Eur Radiol 2010;20:2257-2264.
74.    Mahgerefteh S, Blachar A, Fraifeld S, Sosna J. Dual-energy derived virtual nonenhanced computed tomography imaging: current status and applications. Semin Ultrasound CT MR 2010;31:321-327.
75.    De Cecco CN, Buffa V, Fedeli S, Luzietti M, Vallone A, Ruopoli R, Miele V, Rengo M, Paolantonio P, Maurizi Enrici M, et al. Dual energy CT (DECT) of the liver: conventional versus virtual unenhanced images. Eur Radiol 2010
76.    Lee SH, Lee JM, Kim KW, Klotz E, Kim SH, Lee JY, Han JK, Choi BI. Dual-Energy Computed Tomography to Assess Tumor Response to Hepatic Radiofrequency Ablation: Potential Diagnostic Value of Virtual Noncontrast Images and Iodine Maps. Invest Radiol 2010
77.    Altenbernd J, Heusner TA, Ringelstein A, Ladd SC, Forsting M, Antoch G. Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivity. Eur Radiol 2010
78.    Kim KS, Lee JM, Kim SH, Kim KW, Kim SJ, Cho SH, Han JK, Choi BI. Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies. Invest Radiol 2010;45:149-157.
79.    Bauer RW, Schulz JR, Zedler B, Graf TG, Vogl TJ. Compound analysis of gallstones using dual energy computed tomography–results in a phantom model. Eur J Radiol 2010;75:e74-80.
80.    Voit H, Krauss B, Heinrich MC, Dimmler A, Adamitz B, Hinkmann FM, Uder M, Kuettner A. [Dual-source CT: in vitro characterization of gallstones using dual energy analysis]. Rofo 2009;181:367-373.
81.    Rambow A, Staritz M, Wosiewitz U, Thelen M, Meyer zum Buschenfelde KH. [Computerized tomography differentiation of pigment and cholesterol bile duct calculi]. Z Gastroenterol 1991;29:137-139.
82.    Rambow A, Staritz M, Wosiewitz U, Mildenburger P, Thelen M, Meyer zum Buschenfelde KH. Analysis of radiolucent gallstones by computed tomography for in vivo estimation of stone components. Eur J Clin Invest 1990;20:475-478.
83.    Sommer CM, Schwarzwaelder CB, Stiller W, Schindera ST, Heye T, Stampfl U, Ramsauer S, Bellemann N, Weitz J, Schmidt J, et al. Dual-energy computed-tomography cholangiography in potential donors for living-related liver transplantation: initial experience. Invest Radiol 2010;45:406-412.
84.    Morosi C, Civelli E, Battiston C, Schiavo M, Mazzaferro V, Severini A, Marchiano A. CT cholangiography: assessment of feasibility and diagnostic reliability. Eur J Radiol 2009;72:114-117.
85.    Karlo C, Lauber A, Gotti RP, Baumuller S, Stolzmann P, Scheffel H, Desbiolles L, Schmidt B, Marincek B, Alkadhi H, Leschka S. Dual-energy CT with tin filter technology for the discrimination of renal lesion proxies containing blood, protein, and contrast-agent. An experimental phantom study. Eur Radiol 2010
86.    Brown CL, Hartman RP, Dzyubak OP, Takahashi N, Kawashima A, McCollough CH, Bruesewitz MR, Primak AM, Fletcher JG. Dual-energy CT iodine overlay technique for characterization of renal masses as cyst or solid: a phantom feasibility study. Eur Radiol 2009;19:1289-1295.
87.    Graser A. Abdominal Imaging: Kidney Imaging. In: Johnson TRC, Fink C, Schönberg SO, Reiser MF, eds. Dual Energy CT in Clinical Practice. Heidelberg: Springer, 2010:157-166.
88.    Coursey CA, Nelson RC, Boll DT, Paulson EK, Ho LM, Neville AM, Marin D, Gupta RT, Schindera ST. Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging? Radiographics 2010;30:1037-1055.
89.    Leschka S, Stolzmann P, Baumuller S, Scheffel H, Desbiolles L, Schmid B, Marincek B, Alkadhi H. Performance of dual-energy CT with tin filter technology for the discrimination of renal cysts and enhancing masses. Acad Radiol 2010;17:526-534.
90.    Graser A, Becker CR, Staehler M, Clevert DA, Macari M, Arndt N, Nikolaou K, Sommer W, Stief C, Reiser MF, Johnson TR. Single-phase dual-energy CT allows for characterization of renal masses as benign or malignant. Invest Radiol 2010;45:399-405.
91.    Primak AN, Vrtiska TJ, Qu M, McCollough CH. Abdominal Imaging: Kidney Stone Differentiation In: Johnson TRC, Fink C, Schönberg SO, Reiser MF, eds. Dual Energy CT in Clinical Practice. Heidelberg: Springer, 2010:177-192.
92.    Ascenti G, Siragusa C, Racchiusa S, Ielo I, Privitera G, Midili F, Mazziotti S. Stone-targeted dual-energy CT: a new diagnostic approach to urinary calculosis. AJR Am J Roentgenol 2010;195:953-958.
93.    Thomas C, Heuschmid M, Schilling D, Ketelsen D, Tsiflikas I, Stenzl A, Claussen CD, Schlemmer HP. Urinary calculi composed of uric acid, cystine, and mineral salts: differentiation with dual-energy CT at a radiation dose comparable to that of intravenous pyelography. Radiology 2010;257:402-409.
94.    Hidas G, Eliahou R, Duvdevani M, Coulon P, Lemaitre L, Gofrit ON, Pode D, Sosna J. Determination of renal stone composition with dual-energy CT: in vivo analysis and comparison with x-ray diffraction. Radiology 2010;257:394-401.
95.    Ferrandino MN, Pierre SA, Simmons WN, Paulson EK, Albala DM, Preminger GM. Dual-energy computed tomography with advanced postimage acquisition data processing: improved determination of urinary stone composition. J Endourol 2010;24:347-354.
96.    Stolzmann P, Scheffel H, Rentsch K, Schertler T, Frauenfelder T, Leschka S, Sulser T, Marincek B, Alkadhi H. Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation. Urol Res 2008;36:133-138.
97.    Graser A, Johnson TR, Bader M, Staehler M, Haseke N, Nikolaou K, Reiser MF, Stief CG, Becker CR. Dual energy CT characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol 2008;43:112-119.
98.    Primak AN, Fletcher JG, Vrtiska TJ, Dzyubak OP, Lieske JC, Jackson ME, Williams JC, Jr., McCollough CH. Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol 2007;14:1441-1447.
99.    Eliahou R, Hidas G, Duvdevani M, Sosna J. Determination of renal stone composition with dual-energy computed tomography: an emerging application. Semin Ultrasound CT MR 2010;31:315-320.
100.    Thomas C, Krauss B, Ketelsen D, Tsiflikas I, Reimann A, Werner M, Schilling D, Hennenlotter J, Claussen CD, Schlemmer HP, Heuschmid M. Differentiation of urinary calculi with dual energy CT: effect of spectral shaping by high energy tin filtration. Invest Radiol 2010;45:393-398.
101.    Scheffel H, Stolzmann P, Frauenfelder T, Schertler T, Desbiolles L, Leschka S, Marincek B, Alkadhi H. Dual-energy contrast-enhanced computed tomography for the detection of urinary stone disease. Invest Radiol 2007;42:823-829.
102.    Takahashi N, Hartman RP, Vrtiska TJ, Kawashima A, Primak AN, Dzyubak OP, Mandrekar JN, Fletcher JG, McCollough CH. Dual-energy CT iodine-subtraction virtual unenhanced technique to detect urinary stones in an iodine-filled collecting system: a phantom study. AJR Am J Roentgenol 2008;190:1169-1173.
103.   Takahashi N, Vrtiska TJ, Kawashima A, Hartman RP, Primak AN, Fletcher JG, McCollough CH. Detectability of urinary stones on virtual nonenhanced images generated at pyelographic-phase dual-energy CT. Radiology 2010;256:184-190.
104.    Gupta RT, Ho LM, Marin D, Boll DT, Barnhart HX, Nelson RC. Dual-energy CT for characterization of adrenal nodules: initial experience. AJR Am J Roentgenol 2010;194:1479-1483.
105.    Bauer RW. Abdominal Imaging: Pancreas. In: Johnson TRC, Fink C, Schönberg SO, Reiser MF, eds. Dual Energy CT in Clinical Practice. Heidelberg: Springer, 2010:167-176.
106.    Eliahou R, Azraq Y, Carmi R, Mahgerefteh SY, Sosna J. Dual-energy based spectral electronic cleansing in non-cathartic computed tomography colonography: an emerging novel technique. Semin Ultrasound CT MR 2010;31:309-314.
107.   Godoy MC, Naidich DP, Marchiori E, Leidecker C, Schmidt B, Assadourian B, Vlahos I. Single-acquisition dual-energy multidetector computed tomography: analysis of vascular enhancement and postprocessing techniques for evaluating the thoracic aorta. J Comput Assist Tomogr 2010;34:670-677.
108.    Sommer WH. Vascular System: Aorta. In: Johnson TRC, Fink C, Schönberg SO, Reiser MF, eds. Dual Energy CT in Clinical Practice. Heidelberg: Springer, 2010:61-66.
109.    Numburi UD, Schoenhagen P, Flamm SD, Greenberg RK, Primak AN, Saba OI, Lieber ML, Halliburton SS. Feasibility of dual-energy CT in the arterial phase: Imaging after endovascular aortic repair. AJR Am J Roentgenol 2010;195:486-493.
110.    Sommer WH, Graser A, Becker CR, Clevert DA, Reiser MF, Nikolaou K, Johnson TR. Image quality of virtual noncontrast images derived from dual-energy CT angiography after endovascular aneurysm repair. J Vasc Interv Radiol 2010;21:315-321.
111.    Laks S, Macari M, Chandarana H. Dual-energy computed tomography imaging of the aorta after endovascular repair of abdominal aortic aneurysm. Semin Ultrasound CT MR 2010;31:292-300.
112.    Stolzmann P, Frauenfelder T, Pfammatter T, Peter N, Scheffel H, Lachat M, Schmidt B, Marincek B, Alkadhi H, Schertler T. Endoleaks after endovascular abdominal aortic aneurysm repair: detection with dual-energy dual-source CT. Radiology 2008;249:682-691.
113.    Chandarana H, Godoy MC, Vlahos I, Graser A, Babb J, Leidecker C, Macari M. Abdominal aorta: evaluation with dual-source dual-energy multidetector CT after endovascular repair of aneurysms–initial observations. Radiology 2008;249:692-700.
114.    Alkadhi H, Stolzmann P, Leschka S, Cattin P, Székely G, Saur S. Plaque Differentiation. In: Johnson TRC, Fink C, Schönberg SO, Reiser MF, eds. Dual Energy CT in Clinical Practice. Heidelberg: Springer, 2010:73-82.
115.    Zachrisson H, Engstrom E, Engvall J, Wigstrom L, Smedby O, Persson A. Soft tissue discrimination ex vivo by dual energy computed tomography. Eur J Radiol 2010;75:e124-128.
116.    Henzler T, Porubsky S, Kayed H, Harder N, Krissak UR, Meyer M, Sueselbeck T, Marx A, Michaely H, Schoepf UJ, et al. Attenuation-based characterization of coronary atherosclerotic plaque: Comparison of dual source and dual energy CT with single-source CT and histopathology. Eur J Radiol 2010
117.   Barreto M, Schoenhagen P, Nair A, Amatangelo S, Milite M, Obuchowski NA, Lieber ML, Halliburton SS. Potential of dual-energy computed tomography to characterize atherosclerotic plaque: ex vivo assessment of human coronary arteries in comparison to histology. J Cardiovasc Comput Tomogr 2008;2:234-242.

Comments
  • No comments yet.
Your Comment

All fields are required – your mail will not be published